Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 84
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Urban Pollination: sustain native bees & urban crops

Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...

Cannibalism in Giant Tyrannosaurs

This is the key question we hope to answer with this study. This project is to fund research into a skull...

Seattle HiveBio Community Lab

Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...

Backer Badge Funded